http://web.archive.org/web/20140808132339id_/http://www.dailymail.co.uk/news/article-2621464/How-cancer-drugs-doubled-10-000-month.html

by @entity0 rising costs : cancer drug prices have doubled in the past decade , from an average of $ 5,000 per month to more than $ 10,000 @entity5 drug prices have doubled in the past decade , from an average of $ 5,000 per month to more than $ 10,000			1
eleven of the 12 cancer drugs the @entity8 approved for fighting cancer in 2012 were priced at more than $ 100,000 per year , double the average annual household income thousands of cancer patients , even many with insurance , face the same dire decision : go bankrupt or die			1
many are struggling with a huge jump in the average price tag for branded oncology treatments , which have doubled to $ 10,000 per month in just a decade			2
that jump is contributing to a surge in global spending on oncology treatments , which reached a whopping $ 91 billion last year , according to a new report from the @entity21			0
the @entity22 is the largest segment of that market , with @entity22 patients and their insurers paying $ 37.2 billion for oncology treatments in 2013			1
pharmaceutical companies say it costs on average more than $ 1 billion to research a new drug and bring it to market , but critics put the costs at less than $ 90 million			0
last year 100 cancer specialists suggested that drug prices of $ 100,000 or more for treatments could be viewed as profiteering and may be causing financial harm to patients			1
the pharmaceutical industry is the second most profitable industry in the @entity22 , after the oil and gas industry			2
rising costs : cancer patients are more than two times as likely to file for bankruptcy compared with @entity22 without a cancer diagnosis the top - tier cancer drugs cost twice as much in the @entity22 as they do in parts of @entity48 , @entity49 , @entity50 and the @entity51 , where the government sets a limit on pricing and medications are as much as 38 percent lower			1
as the cost of the pills have more than doubled since 2007 , the @entity56 of the drug companies have earned tens of millions of dollars			2
the companies justify the enormous spend by pointing out the research needed to develop them and the scientific innovation they represent along with thevalue they deliver to patients and physicians			2
however , nearly one in five cancer patients ca n’t afford their medication and even with insurance many are on the hook for covering 20 percent of their drug payments			1
the study also found that patients were less likely to persist with treatment as the costs climbed			0
there is some positive news however , @entity5 survival rates are climbing , with 20 percent of the improvement due to advances in treatment			0
the top - tier cancer drugs cost twice as much in the @entity22 as they do in parts of @entity48 , @entity49 , @entity50 and the @entity51 , where the government sets a limit on pricing and medications are as much as 38 percent lower			1
as the cost of the pills have more than doubled since 2007 , the @entity56 of the drug companies have earned tens of millions of dollars			0
the companies justify the enormous spend by pointing out the research needed to develop them and the scientific innovation they represent along with thevalue they deliver to patients and physicians			0
however , nearly one in five cancer patients ca n’t afford their medication and even with insurance many are on the hook for covering 20 percent of their drug payments			1
the study also found that patients were less likely to persist with treatment as the costs climbed			0
there is some positive news however , @entity5 survival rates are climbing , with 20 percent of the improvement due to advances in treatment .			0

the cost of cancer drugs has **increased** 100 per cent over the last ten years
during the same period , the *consumer* price index has **increased** by *23* per cent
even insured patients may have to pay up to 20 per cent of the cost of drugs
prices are *higher* in the @entity22 than @entity48 where the cost is 38 per cent *cheaper*

@entity22:U.S.
@entity21:IMS Institute for Healthcare Informatics
@entity5:Cancer
@entity8:Food and Drug Administration
@entity0:James Gordon
@entity51:United Kingdom
@entity50:Canada
@entity56:CEOs
@entity48:Europe
@entity49:China